Blackstone Holdings II L.P., 10% Owner at Talaris Therapeutics, Inc. (TALS), bought 306,060 shares at $17.00 ($510K) on 2021-05-11, disclosed to the SEC on 2021-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 276,060 | $0 | 0.0% |
| 2 | $17.00 | 701 | $12K | 2.3% |
| 3 | $17.00 | 1,444 | $25K | 4.8% |
| 4 | $17.00 | 1,902 | $32K | 6.3% |
| 5 | $17.00 | 2,917 | $50K | 9.7% |
| 6 | $17.00 | 3,507 |
| $60K |
| 11.7% |
| 7 | $17.00 | 3,611 | $61K | 12.0% |
| 8 | $17.00 | 15,918 | $271K | 53.1% |
| Total | $1.67 avg | 306,060 | $510K | 100% |
| Filing → |
| BAER | SELL | 2026-08-06 | $3.2M | — | Filing → |
| JMKE | SELL | 2026-08-04 | $648.8M | — | Filing → |
| LGN | SELL | 2026-01-08 | $56.7M | — | Filing → |